A New Technique of Descemet Membrane Endothelial Keratoplasty for Aphakic and Vitrectomized Eyes. | ASCRS
Presentation
A New Technique of Descemet Membrane Endothelial Keratoplasty for Aphakic and Vitrectomized Eyes.
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-101 Corneal Procedures & Diagnostics: EK, PK, CXL, Other
Authors: Daliya Dzhaber, MD, Allen Eghrari MD
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
To describe a new technique for Descemet membrane endothelial keratoplasty (DMEK) in aphakic and vitrectomized eyes.

Methods
This is a retrospective case series performed in a tertiary cornea practice. The study included five eyes which underwent DMEK surgery for corneal endothelial insufficiency for aphakic bullous keratopathy utilizing a new “Parachute” technique. Cases were reviewed for intra- and postoperative complications, postoperative clearing of the cornea, best corrected visual acuity, and endothelial cell loss.

Results
The mean BCVA improved from 1.56±0.68 LogMAR to 1.32±0.74 LogMAR at post-operative month 1 and to 1.10±0.81 at post-operative month 3. The mean endothelial cell density decreased from 2181±697 cells/mm2 pre-optatively to 2018±760 cells/mm2 3 months after surgery. No complications were recorded.

Conclusion
A new technique of DMEK is a safe and effective method to manage bullous keratopathy in aphakic and vitrectomized eyes.
View More Presentations from this Session

This presentation is from the session "SPS-101 Corneal Procedures & Diagnostics: EK, PK, CXL, Other" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.